[Hot Spots].

Tianfeng Securities: The company's price-to-book ratio is higher than the industry median

Tianfeng Securities (601162) issued an announcement on the evening of October 22 on abnormal fluctuations in stock trading, saying that the company's stock trading on October 18, October 21, and October 22, 2024 will have a cumulative deviation of 20% from the daily closing price increase in three consecutive trading days, and on October 22, the company's stock closing price-to-book ratio was 2.04 times, and the securities industry price-to-book ratio was 1.38 times, and the company's price-to-book ratio was higher than the industry median. In view of the recent fluctuations in the company's stock price, investors are advised to pay attention to investment risks.

Fullert: There have been no major changes in the company's operating conditions and internal and external business environment recently

On the evening 301297 of October 22, the company disclosed an announcement on the change of stock trading, and the company is planning a major asset restructuring. The company intends to issue shares and convertible corporate bonds to Shanghai Shenhe Investment Co., Ltd. and other counterparties to purchase 100% of the equity of Jiangsu Fulehua Semiconductor Technology Co., Ltd. held by it. In addition to the above-mentioned major asset restructuring matters under planning, there have been no major changes in the company's operating conditions and internal and external business environment recently. The audit and evaluation work related to this transaction has not yet been completed, and the transaction still needs to perform a number of approval procedures before it can be implemented, and there is uncertainty about whether the transaction can pass the above approval and the time to obtain approval, please pay attention to the company's follow-up announcement and pay attention to investment risks.

Qilianban Shuangcheng Pharmaceutical: There have been no major changes in the company's operating conditions and internal and external business environment in the near future

Qilian Shuangcheng Pharmaceutical (002693) disclosed on October 22 that the company is planning a major asset restructuring: the company intends to purchase 100% of the shares of Ola shares held by 25 counterparties such as Ola Investment and Win Aiming by issuing shares and paying cash, and intends to issue shares to no more than 35 specific investors to raise matching funds. In addition, there have been no major changes in the company's operating conditions and internal and external business environment recently. The audit and evaluation of this transaction have not been completed, and the specific transaction price of this transaction has not yet been determined. The restructuring matters still need to perform the necessary internal decision-making procedures, and need to be approved by the competent regulatory authorities before formal implementation, whether the final successful implementation is uncertain, please pay attention to the follow-up announcement and pay attention to the investment risk.

Waigaoqiao: The controlling shareholder received loan support for the increase in A-share shares

Waigaoqiao (600648) announced on the evening of October 22 that recently, the company received the company's controlling shareholder Shanghai Waigaoqiao Asset Management Co., Ltd. (hereinafter referred to as the "foreign management company") "on obtaining the loan support for the increase of A-share shares". Bank of China intends to provide financing support for foreign-funded management companies to increase their holdings of listed companies' shares, with a loan amount of no more than 480 million yuan, which will be specially used to increase their holdings of Waigaoqiao's A-share shares through centralized bidding transactions.

Anfu Technology: The controlling shareholder acting in concert was supported by a loan to increase his holdings and increased the amount of his holdings

Anfu Technology (603031) announced on the evening of October 22 that Shenzhen Qianhai Glory Capital Management Co., Ltd. (hereinafter referred to as "Qianhai Glory"), the controlling shareholder of the company, intends to increase its holdings of the company's shares, with a planned increase of no less than 300 million yuan, and the source of funds for the increase is self-raised. Recently, Qianhai Glory obtained a loan commitment letter issued by Industrial and Commercial Bank of China Co., Ltd. Nanping Branch (hereinafter referred to as "ICBC Nanping Branch"), and ICBC Nanping Branch promised to provide Qianhai Glory with a loan line of 30 million yuan to 50 million yuan for Qianhai Glory to increase its shareholding in the company through centralized bidding transactions. The actual controller of the company decided to adjust the shareholding increase plan of Qianhai Glory, increasing the amount of increased holdings through centralized bidding from 10.55 million yuan to no less than 50 million yuan, adjusting the source of funds for increasing holdings through centralized bidding transactions to special loans and other self-raised funds, and adjusting the part of holdings other than agreement transfer to increase holdings (originally centralized bidding and block trading) to increase holdings through centralized bidding transactions on the Shanghai Stock Exchange.

Liqun shares: obtained a share repurchase loan from a financial institution

Liqun shares (601366) announced on the evening of October 22 that on October 21, the company signed the "Share Repurchase Loan Contract for Listed Companies" with Qingdao Taitung Branch of Industrial and Commercial Bank of China Co., Ltd., and the company applied for a loan of no more than 180 million yuan from Qingdao Taitung Branch of Industrial and Commercial Bank of China Co., Ltd.

Jinhong Gas: Signed a 48 million yuan share repurchase loan contract

Jinhong Gases (688106) announced on the evening of October 22 that the company decided to adjust the source of repurchase funds from "the company's own funds or self-raised funds" to "its own funds and self-raised funds". In addition to the above adjustments, the other contents of the company's share repurchase plan have not changed. On October 21, the company and Industrial and Commercial Bank of China Co., Ltd. Suzhou Xiangcheng Branch signed the "Listed Company Stock Repurchase Loan Contract": the upper limit of the loan amount is 48 million yuan, the loan period is 12 months, the funds can be withdrawn and used in batches, and the purpose of the loan is the repurchase transaction price.

Milkyway: It is planned to repurchase the company's shares for 75 million yuan - 150 million yuan

Milkyway (603713) announced on the evening of October 22 that the company intends to cancel all the shares repurchased with 75 million yuan - 150 million yuan and reduce the company's registered capital, and the price of the repurchased shares does not exceed 79.5 yuan / share (including 79.5 yuan / share), and the source of funds for the repurchase of shares is the special loan provided by the Shanghai branch of China Merchants Bank Co., Ltd. and the company's own funds, of which the amount of special loans does not exceed 94 million yuan.

Hailiang shares: the controlling shareholder intends to increase his shareholding by 200 million yuan to 300 million yuan

Hailiang shares (002203) announced on the evening of October 22 that the company's controlling shareholder Hailiang Group Co., Ltd. (hereinafter referred to as "Hailiang Group") plans to increase its holdings of the company's shares through centralized bidding transactions on the Shenzhen Stock Exchange within 6 months. There is no price range for this increase, and the total amount of the increase is not less than 200 million yuan and not more than 300 million yuan. At the same time, on October 20, Bank of China Hangzhou Branch issued a "Loan Commitment Letter" to Hailiang Group, agreeing to provide special loan support for Hailiang Group to increase its shareholding in the Company. The maximum loan amount shall not exceed 297 million yuan, and the validity period of the commitment letter shall be one year from the date of issuance.

[M&A and reorganization].

Insai Group: Stocks that plan to plan a major asset restructuring will be suspended from tomorrow

Insai Group (300781) announced on the evening of October 22 that the company is planning to issue shares and pay cash to purchase assets, and the target company of the transaction is the leading digital and intelligent public relations communication service provider in China - Wise Peer Brand Management Consultants (Beijing) Co., Ltd. Trading in the company's shares has been suspended since the market opened on October 23.

Jin Hongshun: Plans for major asset restructuring matters and stocks will be suspended from tomorrow

Jin Hongshun (603922) announced on the evening of October 22 that the company is planning to purchase the equity of New Thinking Motor Co., Ltd. (hereinafter referred to as "New Thinking") by issuing shares and paying cash, and at the same time raise matching funds. According to preliminary estimates, this transaction is expected to constitute a major asset restructuring. The company's shares have been suspended since the market opened on October 23, and the suspension is expected to last no more than 10 trading days.

Longyuan Power: It plans to acquire the shares of 8 new energy companies under the controlling shareholder for 1.686 billion yuan

Longyuan Power (001289) announced on the evening of October 22 that the company intends to acquire the company's controlling shareholder National Energy Group wholly-owned subsidiary of the National Energy Group National Energy Asset Management Company, Guoneng Gansu Electric Power and Guoneng Guangxi Electric Power held a total of 8 new energy company equity in Shandong, Jiangxi, Gansu and Guangxi regions, as of now, the preliminary estimate of the transaction target company equity transfer consideration is 1.686 billion yuan. The total installed capacity of the above-mentioned target companies in operation and under construction is 2,032,900 kilowatts, of which 1,446,900 kilowatts are in operation and 586,000 kilowatts are under construction, 1,316,000 kilowatts are wind power, and 716,900 kilowatts are photovoltaic power.

Hexin Instrument: is planning a major asset restructuring and the stock will be suspended from tomorrow

Hexin Instrument (688622) announced on the evening of October 22 that the company is planning to purchase the control of Shanghai Liangxi Technology Co., Ltd. (hereinafter referred to as "Liangxi Technology") by issuing shares and paying cash, and at the same time raise matching funds, the transaction is expected to constitute a major asset restructuring, the company's shares will be suspended from the opening of the market on October 23, 2024 (Wednesday), and the suspension is expected to last no more than 5 trading days.

Baogang Co., Ltd.: It is planned to absorb and merge its wholly-owned subsidiary, Inner Mongolia Baogang Steel Pipe Co., Ltd

Baogang Co., Ltd. (600010) announced on the evening of October 22 that the company intends to absorb and merge its wholly-owned subsidiary, Inner Mongolia Baogang Steel Pipe Co., Ltd. (hereinafter referred to as "Steel Pipe Company"). After the completion of the merger, the independent legal personality of the steel pipe company will be cancelled, and all assets, creditor's rights and debts and other related rights and obligations of the steel pipe company will be inherited by the company in accordance with the law.

Reddick: Plans to acquire 51% of the shares of Ditz Precision

Reddick (300652) announced on the evening of October 22 that the company signed the "Equity Acquisition Intent Agreement" with Shanghai Ditz Precision Machinery Co., Ltd. (hereinafter referred to as "Ditz Precision") and its shareholders on October 22, intending to acquire 51% of the equity of Ditz Precision by transferring part of the equity held by the above shareholders and increasing capital to Ditz Precision. The target company has a high reputation and influence in the field of R&D and production of precision transmission products, has strong independent research and development capabilities and industry competitiveness, and its technical accumulation and production capacity in the field of precision screw products will help to meet the company's production needs in the field of automotive ball screws.

SDIC Intelligent: It is planned to acquire 55% of the shares of Nanjing Jinding for 24.75 million yuan

SDIC Intelligent (300188) announced on the evening of October 22 that according to the company's strategic planning, electronic data forensics is one of the company's key business layouts. Nanjing Jinding Jiaqi Information Technology Co., Ltd. (hereinafter referred to as "Nanjing Jinding") is in line with the company's strategic positioning, which will help improve the company's digital and intelligent comprehensive ability to serve the digital transformation of the industry of the Commission for Discipline Inspection and the Supervision Commission, and promote the company's long-term development. The company intends to acquire 55% of the shares of Nanjing Jinding held by Wu Chunqing, a natural person shareholder, with its own funds of 24.75 million yuan.

[increase and decrease in holdings, repurchase].

SMIC: E Fund SSE STAR Market 50 ETF reduced its holdings of 1,246,500 A-shares of the company

SMIC (688981) announced on the evening of October 22 that E Fund's 50-component exchange-traded open-ended index securities investment fund on the SSE Science and Technology Innovation Board reduced its holdings of 1,246,500 shares of the company's domestic stocks. After the reduction, it still holds 99,240,700 shares of the company's domestic shares, accounting for 4.99% of the company's total domestic share capital and 1.24% of the company's total share capital. E Fund SSE STAR Market 50 Component ETF (the "Fund") is an ETF listed and traded on the Shanghai Stock Exchange, with the investment objective of closely tracking the underlying index, the SSE STAR Market 50 Component Index, and pursuing the minimization of tracking difference and tracking error. The Fund mainly adopts a full replication method, that is, the Fund's equity portfolio is constructed according to the composition and weighting of the constituent stocks of the underlying index, and adjusted accordingly according to the changes in the constituents of the underlying index and their weights.

Highpower Technology: The controlling shareholder proposed to repurchase shares for 100 million to 200 million yuan

Highpower Technology (001283) announced on the evening of October 22 that Pan Dangyu, the company's controlling shareholder, actual controller, chairman and general manager, proposed that the company repurchase shares again, with a total amount of funds of not less than 100 million yuan and no more than 200 million yuan, which is intended to be used for equity incentive plans, employee stock ownership plans or convertible corporate bonds to shares.

Changyingtong: Shareholders intend to reduce their holdings of no more than 3% of the company's shares

Changyingtong (688143) announced on the evening of October 22 that Xin Jun, a shareholder holding 5.31% of the shares, plans to reduce his holdings of the company's shares by a total of no more than 3,671,100 shares through block transactions and centralized bidding transactions, accounting for no more than 3% of the company's total share capital.

Shudao Equipment: Jianyang Gangtong plans to reduce its holdings of no more than 2.05% of the company's shares

Shudao Equipment (300540) announced on the evening of October 22 that Sichuan Jianyang Gangtong Economic and Technological Development Co., Ltd. (hereinafter referred to as "Jianyang Gangtong"), a shareholder of 5.9071% of the company, plans to reduce the company's shares by a total of no more than 3.39 million shares (no more than 2.0499% of the company's total share capital) within three months after 15 trading days.

Yinghantong: Shareholder Defengjie intends to reduce his holdings of no more than 2% of the company's shares

Yinghantong (688080) announced on the evening of October 22 that Changzhou Defengjie Clean Technology Venture Capital Center (Limited Partnership) (hereinafter referred to as "Defengjie"), a shareholder of 4.21%, intends to reduce its holdings of the company's shares through centralized bidding on the stock exchange due to the needs of corporate funds, with a total of no more than 1.472 million shares, that is, no more than 2% of the company's total share capital.

Huace Film and Television: The concerted action of the actual controller intends to reduce the company's shares by no more than 0.68%.

Huace Film and Television (300133) announced on the evening of October 22 that Yinwan Quanying No. 31 Fund and Yinwan Quanying No. 32 Fund, the concerted actors of the company's actual controllers, intend to reduce their holdings of the company by no more than 12.659 million shares through centralized bidding transactions and block transactions, that is, no more than 0.68% of the company's existing total share capital.

[Business data].

Wen's shares: net profit in the third quarter was 5.081 billion yuan, a year-on-year increase of 3097.03

Wen's shares (300498) disclosed the third quarterly report on the evening of October 22, the company's operating income in the third quarter was 28.644 billion yuan, a year-on-year increase of 21.89%; net profit attributable to shareholders of listed companies was 5.081 billion yuan, a year-on-year increase of 3097.03%; Basic earnings per share was 0.76 yuan. In the first three quarters, the company achieved operating income of 75.384 billion yuan, a year-on-year increase of 16.53%; net profit attributable to shareholders of listed companies was 6.408 billion yuan, a year-on-year turnaround.

China Telecom: net profit in the third quarter was 7.487 billion yuan, a year-on-year increase of 7.8

China Telecom (601728) disclosed its third quarterly report on the evening of October 22, the company's operating income in the third quarter of 2024 was 125.995 billion yuan, a year-on-year increase of 2.9%, net profit was 7.487 billion yuan, a year-on-year increase of 7.8%, and basic earnings per share were 0.08 yuan. In the first three quarters of 2024, the company's mobile communication service revenue reached 156.823 billion yuan, a year-on-year increase of 3.2%, with a net increase of 14.9 million mobile users to 423 million, a net increase of 26.4 million 5G package users to 345 million, a penetration rate of 81.6%, and a mobile user ARPU1 of 45.6 yuan, which remained stable.

China Unicom: In the first three quarters, the profit attributable to the company's equity holders was 19.03 billion yuan, a year-on-year increase of 10.3

China Unicom announced on the evening of October 22 on the Hong Kong Stock Exchange that in the first three quarters of 2024, the group's operating income was 290.12 billion yuan, a year-on-year increase of 3%; The profit attributable to equity holders of the company was 19.03 billion yuan, a year-on-year increase of 10.3%, maintaining a double-digit growth rate. The number of mobile users reached 345 million, with a cumulative net increase of 11.23 million, a new high in the same period in the past six years, and the computing power business grew rapidly, with China Unicom's cloud revenue reaching 43.86 billion yuan, an increase of 19.5% year-on-year.

Xiaocheng Technology: Net profit in the third quarter increased by 597.01% year-on-year

Xiaocheng Technology (300139) disclosed the third quarter report on the evening of October 22, and the company's operating income in the first three quarters was 237 million yuan, a year-on-year increase of 28.44%; the net profit attributable to the parent company was 40.6474 million yuan, a year-on-year decrease of 3.2%; Basic earnings per share was 0.15 yuan. Among them, the company's net profit attributable to the parent company in the third quarter was 20.8305 million yuan, a year-on-year increase of 597.01%.

Ruiming Technology: Net profit in the third quarter increased by 360.26% year-on-year

Ruiming Technology (002970) disclosed the third quarter report on the evening of October 22, and the company's operating income in the third quarter was 766 million yuan, a year-on-year increase of 65.79%; net profit attributable to shareholders of listed companies was 96.633 million yuan, a year-on-year increase of 360.26%.

Bowes: net profit in the first three quarters increased by 303.09% year-on-year

Bowes shares (300441) disclosed the third quarter report on the evening of October 22, the company's operating income in the first three quarters was 1.769 billion yuan, a year-on-year increase of 6.74%; the net profit attributable to the parent company was 703 million yuan, a year-on-year increase of 303.09%; Basic earnings per share was 1.08 yuan. Among them, the company's net profit attributable to the parent company in the third quarter was 515 million yuan, a year-on-year increase of 519.91%. The company completed the equity delivery of Arnold Precision in July 2024, achieving an investment income of 681 million yuan and a net profit attributable to shareholders of the listed company of 472 million yuan. After the completion of the transaction, Arnold Precision will no longer be included in the scope of consolidation in the reporting period, which will affect the operating income and total assets in the third quarter.

Rockchip: net profit in the third quarter was 169 million yuan, a year-on-year increase of 221.68

Rockchip Micro (603893) disclosed its third quarterly report on the evening of October 22, and the company's operating income in the first three quarters was 2.16 billion yuan, a year-on-year increase of 48.47%; The net profit attributable to the parent company was 352 million yuan, a year-on-year increase of 354.9%. Among them, the operating income in the third quarter was 911 million yuan, a year-on-year increase of 51.36%; The net profit attributable to the parent company in the third quarter was 169 million yuan, a year-on-year increase of 221.68%. In the first three quarters of 2024, the demand for AIoT product lines showed mass growth. Relying on the company's continuous growth in AIoT, especially in the automotive electronics, as well as the improvement of industrial, industrial, industrial, consumer and other markets, and the third quarter is the traditional peak season for the industry, the company's revenue in the third quarter hit a record high in a single quarter.

Zhongji Innolight: Net profit in the first three quarters increased by 189.59% year-on-year

Zhongji Innolight (300308) disclosed its third quarterly report on the evening of October 22, and the company achieved operating income of 17.313 billion yuan in the first three quarters, a year-on-year increase of 146.26%; the net profit attributable to shareholders of the listed company was 3.753 billion yuan, a year-on-year increase of 189.59%; Basic earnings per share was 3.42 yuan. Among them, the company's operating income in the third quarter was 6.514 billion yuan, a year-on-year increase of 115.25%; The net profit attributable to shareholders of the listed company was 1.394 billion yuan, a year-on-year increase of 104.4%. The main reason is that the growth of computing power infrastructure construction and related capital expenditures has led to a significant increase in sales of 800G and 400G high-end optical modules.

Tengyuan Cobalt: Net profit in the first three quarters increased by 156.09% year-on-year

Tengyuan Cobalt (301219) disclosed the third quarter report on the evening of October 22, and the company achieved operating income of 4.889 billion yuan in the first three quarters, a year-on-year increase of 23.11%; the net profit attributable to the parent company was 617 million yuan, a year-on-year increase of 156.09%; Basic earnings per share was 2.1 yuan.

Nuotai Bio: net profit in the third quarter was 123 million yuan, a year-on-year increase of 146.86

Nuotai Biotechnology (688076) disclosed its third quarterly report on the evening of October 22, the company achieved operating income of 421 million yuan in the third quarter of 2024, a year-on-year increase of 36.31%, a net profit of 123 million yuan, a year-on-year increase of 146.86%, and basic earnings per share of 0.58 yuan. In the third quarter of this year, the company's revenue from peptide APIs increased significantly year-on-year.

Tianfu Communication: Net profit in the first three quarters increased by 122.39% year-on-year

Tianfu Communication (300394) disclosed the third quarter report on the evening of October 22, and the company achieved operating income of 2.395 billion yuan in the first three quarters, a year-on-year increase of 98.55%; net profit attributable to the parent company was 976 million yuan, a year-on-year increase of 122.39%; Basic earnings per share was 1.76 yuan. Among them, the company's net profit attributable to the parent company in the third quarter was 322 million yuan, a year-on-year increase of 58.69%. Mainly due to the development of AI technology and the increase in demand for computing power, the construction of global data centers has driven the continuous and stable growth of demand for high-speed optical device products, especially the rapid growth of demand for high-speed products, which has brought the company's revenue year-on-year.

Boke New Materials: net profit in the third quarter increased by 84.73% year-on-year

Boke New Materials (300811) disclosed the third quarter report on the evening of October 22, and the company's operating income in the first three quarters was 1.227 billion yuan, a year-on-year increase of 43.63%; the net profit attributable to the parent company was 286 million yuan, a year-on-year increase of 51.69%; Basic earnings per share was 1.02 yuan. Among them, the company's net profit attributable to the parent company in the third quarter was 101 million yuan, a year-on-year increase of 84.73%. The company continues to focus on building three growth curves of metal soft magnetic powder core, chip inductor and metal soft magnetic powder, and its business work is progressing steadily.

Liugong: Net profit in the first three quarters increased by 59.82% year-on-year

Liugong (000528) disclosed the third quarter report on the evening of October 22, and the company's operating income in the first three quarters was 22.856 billion yuan, a year-on-year increase of 8.25%; the net profit attributable to the parent company was 1.321 billion yuan, a year-on-year increase of 59.82%; Basic earnings per share was 0.68 yuan. Among them, the company's net profit attributable to the parent company in the third quarter was 337 million yuan, a year-on-year increase of 58.74%.

Gan & Lee Pharmaceutical: net profit in the third quarter was 208 million yuan, a year-on-year increase of 57.47

Gan & Lee Pharmaceutical (603087) disclosed its third quarterly report on the evening of October 22, the company achieved operating income of 930 million yuan in the third quarter of 2024, a year-on-year increase of 37.61%, a net profit of 208 million yuan, a year-on-year increase of 57.47%, and basic earnings per share of 0.35 yuan. In the second quarter of 2024, the company actively participated in the bidding for the national centralized drug procurement (insulin special continuation) organized by the state, and all products were successfully selected. The price of the selected products of the centralized procurement company has risen. The new round of centralized insulin procurement was successively implemented by the provinces in the second and third quarters, and the revenue growth effect brought by the company's product price increase was initially partially reflected in the third quarter.

Haixing shares: net profit in the third quarter was 53.233 million yuan, a year-on-year increase of 55.79

Haixing shares (603115) disclosed the third quarterly report on the evening of October 22, the company achieved operating income of 510 million yuan in the third quarter of 2024, a year-on-year increase of 12.2%, a net profit of 53.233 million yuan, a year-on-year increase of 55.79%, and basic earnings per share of 0.22 yuan. During the reporting period, the number of products provided by the company to meet the needs of emerging markets increased significantly, and the capacity utilization rate continued to maintain a high level.

Hangzhou Electric Co., Ltd.: net profit in the third quarter was 50.6926 million yuan, a year-on-year increase of 48.85

Hangzhou Electric Co., Ltd. (603618) disclosed its third quarterly report on the evening of October 22, the company achieved operating income of 2.569 billion yuan in the third quarter of 2024, a year-on-year increase of 28.86%, a net profit of 50.6926 million yuan, a year-on-year increase of 48.85%, and basic earnings per share of 0.07 yuan. During the reporting period, the net profit increased due to the year-on-year increase in operating income and value-added tax deduction income.

Longgao shares: net profit in the third quarter was 50.9373 million yuan, a year-on-year increase of 40.04

Longgao shares (605086) disclosed the third quarterly report on the evening of October 22, the company achieved operating income of 99.3748 million yuan in the third quarter of 2024, a year-on-year increase of 14.42%, a net profit of 50.9373 million yuan, a year-on-year increase of 40.04%, and basic earnings per share of 0.28 yuan. During the reporting period, the company's sales volume increased, resulting in an increase in sales revenue; Gross margin increased due to lower divestiture expenses and higher production volumes; The investment income of 4.396 million yuan was recognized in the Chaozhou Longyan project according to the shareholding ratio of 40%, which did not occur in the same period last year.

Yealink Network: Net profit in the first three quarters increased by 27.91% year-on-year

Yealink Network (300628) disclosed its third quarter report on the evening of October 22, and the company's operating income in the first three quarters was 4.11 billion yuan, a year-on-year increase of 27.49%; the net profit attributable to the parent company was 2.065 billion yuan, a year-on-year increase of 27.91%; Basic earnings per share was 1.63 yuan. Among them, the company's net profit attributable to the parent company in the third quarter was 704 million yuan, a year-on-year increase of 20.47%.

Huaxiang shares: net profit in the first three quarters was 341 million yuan, a year-on-year increase of 21.18

Huaxiang shares (603112) disclosed the third quarterly report on the evening of October 22, the company achieved operating income of 2.787 billion yuan in the first three quarters of 2024, a year-on-year increase of 18.45%, a net profit of 341 million yuan, a year-on-year increase of 21.18%, and basic earnings per share of 0.79 yuan.

Petty shares: net profit of 155 million yuan in the first three quarters turned around a year-on-year loss

Petit shares (300673) disclosed the third quarter report on the evening of October 22, the company's operating income in the first three quarters was 1.323 billion yuan, a year-on-year increase of 44.34%; The net profit attributable to the parent company was 155 million yuan, compared with a loss of 29.1596 million yuan in the same period last year, and the basic earnings per share was 0.6251 yuan. Among them, the company's net profit attributable to the parent company in the third quarter was 56.856 million yuan, a year-on-year increase of 319.98%.

Dabeinong: net profit in the third quarter was 289 million yuan, a year-on-year turnaround

Dabeinong (002385) disclosed its third quarterly report on the evening of October 22, and the company achieved operating income of 20.142 billion yuan in the first three quarters, a year-on-year decrease of 15.83%; The net profit attributable to shareholders of the listed company was 133 million yuan, compared with a loss of 908 million yuan in the same period last year, and the basic earnings per share was 0.03 yuan. Among them, the company's net profit attributable to the parent company in the third quarter was 289 million yuan, compared with a loss of 134 million yuan in the same period last year.

Sino Biological: Net profit in the first three quarters decreased by 51.6% year-on-year

Sino Biological (301047) disclosed its third-quarter report on the evening of October 22, and the company's operating income in the first three quarters was 465 million yuan, a year-on-year decrease of 2.33%; the net profit attributable to the parent company was 99.3153 million yuan, a year-on-year decrease of 51.6%; Basic earnings per share was 0.78 yuan. The company's net profit attributable to the parent company in the third quarter was 28.3747 million yuan, a year-on-year decrease of 59.2%. The decrease in net profit was mainly due to the decline in income from unconventional businesses, the fluctuation of cash management income, and the fact that the Suzhou subsidiary and the Bioengineering Center (C4B) were still in the early stage of business development and had not formed a revenue scale, which could not cover the operating costs for the time being.

[Winning the Contract].

Xingmin Zhitong: The subsidiary signed a major daily operation contract

Xingmin Zhitong (002355) announced on the evening of October 22 that the company's subsidiaries Anhui Xingmin Haizhi Equity Investment Co., Ltd., Anhui Xinyangfan Shipbuilding Co., Ltd. and Wuhu Shipyard Co., Ltd. signed a "cooperation agreement". According to the above-mentioned Cooperation Agreement, the parties will carry out business cooperation between 2025 and 2029 on a total of 37 ships of various types, including 8 89K bulk carriers, 1 7000PCTC (automobile ro-ro carrier), 1 14600 heavy crane ship, 6 38K stainless steel chemical tankers, 4 49K oil and chemical tankers, 7 50K oil and chemical tankers, and 10 27650DWT multipurpose ships. Among them, in 2025, it will carry out business cooperation with a total of 424 million US dollars, including 8 89K bulk carriers and 1 7000PCTC automobile ro-ro carrier.

Hongjing Technology: Signed a service contract of 409 million yuan for intelligent computing projects

Hongjing Technology (301396) announced on the evening of October 22 that recently, the company signed the "Intelligent Computing Project Service Contract" with Shenzhen X Company, and the company will provide hardware resource equipment, networking supporting services and necessary server configuration services to X Company in accordance with the requirements of X Company, and provide computing power services. The total amount of the contract is 409 million yuan, and the contract period is three years.

Hangzhou Colin: Signed a 248 million yuan lithium iron phosphate battery equipment procurement contract

Hangzhou Colin (688611) announced on the evening of October 22 that the company recently signed a lithium iron phosphate battery equipment procurement contract with MCC Jingcheng Engineering Technology Co., Ltd. for the Alxa Ala Teng Ao Bao 100,000 kW/400,000 kWh grid-side energy storage power station project, with a total contract amount of 248 million yuan (tax included). This transaction belongs to the company's daily operation business, and the total contract price accounts for about 122.77% of the company's audited operating income in 2023. If the contract is successfully executed, it is expected to have a positive impact on the company's operating results in 2024 and 2025.

Mercedes-Benz Information: Pre-won the bid for China Telecom's server (2024-2025) centralized procurement project

Mercedes-Benz Information (300571) announced on the evening of October 22 that recently, the company pre-won the bid for the centralized procurement project of China Telecom server (2024-2025), the procurement content is a general-purpose server, and the company is the winning candidate for the third bid package, and the winning bid amount is about 63.786 million yuan including tax.

Jingu shares: received the fixed-point notice of the Avatar low-carbon wheel project

Jingu shares (002488) announced on the evening of October 22 that the company recently received a designated notice from a leading domestic commercial vehicle company, the company will be used as a parts supplier for customers to develop Avatar low-carbon wheel light truck products, and the company will complete product development and delivery in accordance with customer requirements. The above-mentioned projects are scheduled to be mass-produced by the end of this year and are not expected to have a significant impact on the company's revenue and profit level for the current year. The company's Avatar low-carbon wheels were designated for the customer's heavy truck project for the first time in October last year, and this time the customer's light truck project was designated, which is a manifestation of the continuous expansion and deepening of the cooperative relationship between the two parties.

[Significant investment].

Lihu Co., Ltd.: Jointly established a joint venture company with Gaoneng Times to develop all-solid-state sulfide battery related industrialization technology

Lihu Co., Ltd. (300694) announced on the evening of October 22 that on October 21, 2024, the company signed a "Cooperation Agreement" with Gaoneng Times (Shenzhen) New Energy Technology Co., Ltd. (hereinafter referred to as "Gaoneng Times") to jointly invest in the establishment of a limited liability company as a joint laboratory carrier to develop all-solid-state sulfide battery related industrialization technologies. The registered capital of the project company is 22 million yuan, of which 12 million yuan is subscribed by Gaoneng Times, accounting for 54.55% of the registered capital of the project company; Lihu shares subscribed and contributed 10 million yuan, accounting for 45.45% of the registered capital of the project company.

[Other].

Humanwell Pharmaceutical: The company and its controlling shareholder were filed by the CSRC on suspicion of violating laws and regulations

Humanwell Pharmaceutical (600079) announced on the evening of October 22 that the company and its controlling shareholder Wuhan Modern Technology Industry Group Co., Ltd. (hereinafter referred to as "Modern Technology") received the "Notice of Case Filing" from the China Securities Regulatory Commission on October 22. At present, the company's production and operation activities are carried out normally.

ST Tesco: Filed an arbitration against Wanda Group to demand payment of 5.041 billion yuan for share repurchase

ST Tesco (002024) announced on the evening of October 22 that the company recently received a notice of acceptance from the China International Economic and Trade Arbitration Commission, and the arbitration request submitted by the company has been accepted. A trial has not yet been held. The Company requested that Dalian Wanda Group Co., Ltd. ("Wanda Group") pay RMB 5.041 billion for share repurchase to the Company and its subsidiary, Suning International. At the same time, it requested that Dalian Wanda Commercial Management Group Co., Ltd. (hereinafter referred to as "Wanda Commercial Management") be jointly and severally liable for the above-mentioned payment obligations of Wanda Group. It is requested that Wanda Group and Wanda Commercial Management bear all the costs of the case, including arbitration fees, preservation fees, insurance premiums, and attorney's fees.

Kaishan Co., Ltd.: Kenya's Menengai 35 MW geothermal power plant project received a start-up order

Kaishan Co., Ltd. (300257) announced on the evening of October 22 that Kaishan Renewable Energy Development Pte., Ltd., a subsidiary of the company, completed the acquisition of 100% of the shares of Orpower Twenty Two Limited (hereinafter referred to as the "project company") on December 28, 2023. The latter is constructing and operating a 35 MW geothermal power plant in Menengai under a steam supply and purchase agreement with Kenya geothermal development company Geothermal Development Company (GDC) and a 35 MW power purchase agreement with Kenya Power & Lighting Company (KPLC), a Kenya power company. On 22 October, GDC issued a formal commencement order to the project company. According to the SUPPA, the project company is required to complete the Menengai 35 MW power plant within 17 months from 1 November 2024.

Dishengli: The holding company plans to sell the warehouse land and above-ground buildings for $10.55 million

Dishengli (603335) announced on the evening of October 22 that Wheel Mart Texas Inc, the company's holding company, intends to sell the warehouse land and above-ground buildings at 4520 South Bucknabid, Dallas, Texas to CanTex RE Holdings, LLC for a sale amount of $10.55 million.

Daikin Heavy Industries: The company's first self-transportation overseas offshore project successfully arrived and delivered to Hong Kong

Daikin Heavy Industries (002487) announced on the evening of October 22 that Penglai Daikin, a wholly-owned subsidiary of the company, signed a supply contract with RWE in May 2023 for the Denmark Thor offshore wind farm project, and Penglai Daikin will build and deliver 36 TP-less (no transition section) monopiles for the project, and is responsible for transporting all monopile products to the customer's designated location. Recently, the first batch of 8 monopiles of the project has successfully arrived at the destination port. This project is the first batch of monopile products without transition section built by the company, and it is also the first overseas offshore project that the company is responsible for transportation independently.

Xingqi Ophthalmic: Withdrew the registration application for promecaine hydrochloride eye drops

Xingqi Ophthalmology (300573) announced on the evening of October 22 that recently, the company received the "Notice of Termination of Drug Registration Application" approved and issued by the State Food and Drug Administration, and agreed to withdraw the company's registration application for promecaine hydrochloride eye drops. In December 2023, the company submitted a generic drug registration application for promecaine hydrochloride eye drops to the State Food and Drug Administration, which was accepted, and the declared indication is: for ophthalmic local anesthesia. Affected by changes in policies and regulations, combined with the market registration declaration and the company's R&D strategy, the company decided to withdraw the registration application voluntarily after careful research. The voluntary withdrawal and termination of the drug registration application will not have a significant impact on the company's research and development work, nor will it have a significant impact on the company's current and future production, operation and performance.

Shu Taishen: The first subject was dosed in the phase I clinical trial of STSP-0902 eye drops

Shutaishen (300204) announced on the evening of October 22 that the company received the "Drug Clinical Trial Approval Notice" for STSP-0902 eye drops for the treatment of neurotrophic keratitis issued by the State Food and Drug Administration in July 2024, and agreed to carry out clinical trials of this product for neurotrophic keratitis. Recently, STSP-0902 eye drops completed the administration of the first subject in the phase I clinical trial for neurotrophic keratitis at Beijing Tongren Hospital affiliated to Capital Medical University.

Hisun Pharmaceutical: The holding company obtained the approval number of veterinary drug products

Hisun Pharmaceutical (600267) announced on the evening of October 22 that recently, Yunsheng Company, the company's holding company, received the approval number of the veterinary drug product approval document for the triple inactivated vaccine (WH-2017 strain + LZ-2016 strain + CS-2016 strain) approved and issued by the Ministry of Agriculture and Rural Affairs of the People's Republic of China.

Shenzhou Cell: The recombinant respiratory syncytial virus vaccine SCTV02, a holding subsidiary, was approved for clinical trials

Shenzhou Cell (688520) announced on the evening of October 22 that recently, Shenzhou Cell Engineering Co., Ltd., a holding subsidiary of the company, received the drug clinical trial approval notice approved and issued by the State Drug Administration, and agreed that the company's self-developed recombinant respiratory syncytial virus vaccine product SCTV02 injection will carry out clinical trials for the prevention of respiratory diseases caused by respiratory syncytial virus infection in healthy people aged ≥ 18 years old.

Dorui Pharmaceutical: The subsidiary received the notice of acceptance of the drug registration of amisulpride injection

Dorui Pharmaceutical (301075) announced on the evening of October 22 that recently, Hubei Dorui Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received the notice of acceptance of the drug registration of amisulpride injection issued by the State Food and Drug Administration. Amsulopride injection is a selective dopamine-2 (D2) and dopamine-3 (D3) receptor antagonist.

Huiyu Pharmaceutical: Acetylcysteine injection obtained the drug registration certificate

Huiyu Pharmaceutical (688553) announced on the evening of October 22 that the company recently received the drug registration certificate for acetylcysteine injection approved and issued by the State Drug Administration, and the indication of acetylcysteine injection is acute acetaminophen poisoning and detoxification, which is used to prevent or alleviate liver damage caused by overdose.

First Pharma: The New Drug Application (NDA) for ALK inhibitor Contaitinib Granules (CT-707) was accepted

First Pharma Holdings (688197) announced on the evening of October 22 that the company recently received an acceptance notice issued by the National Medical Products Administration, and the new drug application (NDA) for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) was accepted.

Taiji Group: Penicillin sodium for injection passed the consistency evaluation of generic drugs

Taiji Group (600129) announced on the evening of October 22 that the company's holding subsidiary, Southwest Pharmaceutical, received the State Drug Administration's notice of approval of the supplementary application for penicillin sodium for injection (specification: 0.48g, 0.96g, 2.4g), and the sodium penicillin for injection of Southwest Pharmaceutical Co., Ltd. passed the consistency evaluation of the quality and efficacy of generic drugs, and penicillin is suitable for various infections caused by sensitive bacteria, such as abscess, bacteremia, pneumonia and endocarditis. In addition, Southwest Pharmaceutical received a drug registration certificate from the National Medical Products Administration for oxycodone hydrochloride extended-release tablets (specification: 10mg), which is suitable for relieving persistent moderate to severe pain.

Walvax Biologics: Its subsidiary 13-valent pneumonia conjugate vaccine obtained the product registration certificate of the Sultanate of Oman

Walvax Biotech (300142) announced on the evening of October 22 that the 13-valent pneumococcal polysaccharide conjugate vaccine (English trade name "Weuphoria", referred to as "13-valent pneumococcal conjugate vaccine") produced by the company's subsidiary Yuxi Watson Biotechnology Co., Ltd. recently received the "Product Registration Certificate" issued by the Drug Safety Center of the Ministry of Health of the Oman Sultanate.